Causal Inference in Randomized Controlled Trials

Music City Center 

Room: CC-110A 

One key goal of drug development is to assess causal effects of investigational treatments compared to control treatments. Randomized controlled trials (RCTs) have traditionally served as the basis for establishing these causal effects. While the ICH E9(R1) pharmaceutical guideline does not use the word 'causal', its ideas around precisely defining treatment effects using potential outcomes (estimands) are closely related to causal inference. Indeed, oftentimes causal inference methods are needed to address intercurrent events (post-randomization events that affect the interpretation or existence of outcomes). We believe there is a need to raise awareness of the role of causal inference in RCTs and to prepare statisticians working on clinical trials with knowledge of causal inference tools appropriate to RCT settings.

This half-day short course introduces the basic concepts of causal inference and specific topics that are most relevant to RCTs. We start with a general introduction to causal inference including main assumptions and an overview of the role of causal inference in RCTs. Specific topics include estimation of causal effects, principal stratum estimands, and conditional and marginal treatment effects, with emphasis on their applications in RCTs. The course assumes basic familiarity with statistical inference. Prior knowledge of causal inference is not required.

Biopharmaceutical Section